Immutep Limited Profile

USD 0.00  0.00%

Immutep Limited Summary

Immutep Limited (PBMD) is traded on NASDAQ General Markets in USA. It is located in Sydney, NSW and employs 31 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 46.7 M. Immutep Limited has 0 outstanding shares of which 137.1 K shares are at this time shorted by private and institutional investors with about 1.25 trading days to cover. Prima BioMed Ltd currently holds about 9.74 M in cash with (6.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Check Immutep Limited Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Immutep Limited Risk Profiles

Key Fundamentals

Immutep Limited Against Markets

  The entity Immutep Limited with a symbol PBMD was delisted from NASDAQ General Markets. Please use Immutep Limited with a symbol IMMP from now on.

Diversify with Immutep Limited

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Immutep Limited to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Immutep Limited Corporate Directors
Pete Meyers Non-Executive Director, MBA
Russell Howard Non-Executive Director, Ph.D
Larisa Chisholm Director of Industry Liaison and Devel. and Director of Intellectual Property